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LETTERS
data may be confusing because of 
potential cross-reactions with other 
ﬂ  avivirus antibodies (in particular in 
Chad with West Nile virus).
Because of probable 
underreporting from the ﬁ  eld,  our 
reported number of conﬁ  rmed dengue 
cases likely underestimates the actual 
number of cases among French troops 
stationed in Africa. Nonetheless, our 
data complement those reported by 
Amarasinghe et al. by demonstrating 
additional locations for circulation 
of serotype 1 (Cameroon, Djibouti, 
Gabon, Mayotte) and serotype 3 
(Comoros). Military epidemiologic 
surveillance systems can detect 
dengue circulation where soldiers 
stay. Thus, these systems could 
serve to evaluate the risk for dengue 
infection in countries without local 
epidemiologic surveillance systems, 
thereby improving knowledge 
about dengue circulation in African 
countries.
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To the Editor:  Mycoplasma 
pneumoniae is responsible for ≈20% 
of all cases of community-acquired 
pneumonia. The most common form 
of the infection is tracheobronchitis, 
for which an etiologic diagnosis 
is seldom reached (1). Although 
tracheobronchitis is often mild, 
the infection is disruptive, with the 
cough lasting several weeks, and 
consumes substantial resources (2). 
M. pneumoniae infections occur 
endemically and epidemically 
worldwide, especially in children 
and young adults (1). In 2010, an 
increased incidence was reported from 
Denmark (3), England and Wales (4), 
and Israel (5). Several outbreaks have 
been reported in closed or semiclosed 
settings, as indicated on the basis 
of similar clinical symptoms, chest 
radiograph results, and detection of 
the bacteria (1). 
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Table. Countries in Africa with evidence of dengue virus transmission among French Armed Forces, 1998–2010 
Country and year  No. cases  Testing method  Infection status  Dengue virus serotype 
Cameroon, 2010  1  PCR  Confirmed  1 
Cape Verde, 2010  5  Culture  Confirmed  3 
Central African Republic, 1995  1  Serology  Probable  Unknown 
Chad, 1998–2001, 2003, 2006, 2009–2010  28  Serology  Probable  Unknown 
Comoros        
 2010  1  PCR,  culture  Confirmed    1 
 2010  2  PCR  Confirmed  3 
Côte d’Ivoire         
 1999  1  Culture  Confirmed  1 
 2000,  2004–2007  11  Serology  Probable  Unknown 
 2010  1  PCR  Confirmed  3 
Djibouti        
 1998  4  Culture  Confirmed  1 
 1998  24  Serology  Probable  Unknown 
 2000  2  Culture  Confirmed  1 
 2000  4  Serology  Probable  Unknown 
 2001–2005  123  Serology  Probable  Unknown 
 2005  1  PCR  Confirmed  ND 
 2006  4  Serology  Probable  Unknown 
 2008  2  Serology  Probable  Unknown 
Gabon        
 1998,  2006–2008  22  Serology  Probable  Unknown 
 2010  1  PCR  Confirmed  1 
Mayotte, 2009  1  Culture  Confirmed  1 
Senegal, 2009  1  PCR  confirmed  3 
Somalia, 1999  1  culture  confirmed  2 LETTERS
Previous  M. pneumoniae typing 
methods were based on the analysis 
of the gene encoding the cytadhesin 
P1 (MPN141) or the gene MPN528a 
(6). These methods only enabled the 
separation of isolates into 2 types 
and a few variants; therefore, clinical 
isolates were previously poorly 
differentiated. We recently developed 
a multilocus variable-number tandem 
repeat analysis (MLVA), based on 
the study of the whole genome, 
that can differentiate >26 distinct 
variable-number tandem repeat types 
(7). We report the use of this MLVA 
typing method to show evidence of 
a clonal spread of a unique strain of 
M. pneumoniae among children in 
a French primary school and their 
household contacts.
In January 2011, 6 children (4–9 
years of age), who attended the same 
primary public school in Bordeaux, 
France, reported fever, pharyngitis, 
rhinorrhea, and dry cough that later 
became mucoid. One of the children 
was admitted to the pediatric ward of 
the University Hospital of Bordeaux, 
and atypical pneumonia was conﬁ  rmed 
by radiologic testing. A diagnosis of 
tracheobronchitis was conﬁ  rmed  by 
general practitioners for the 5 other 
children. Three of the children were 
administered  β-lactam antimicrobial 
drugs that did not modify the course 
of the illness. An additional child (4 
years of age), a ﬁ  rst cousin of one of 
the 6 case-patients, also received a 
diagnosis of tracheobronchitis after 
repeated contact with his cousin.
Throat swab or blood samples 
were obtained from the 7 children, and 
throat swab samples were obtained 
from the household members of 4 of 
their families. DNA was extracted 
from throat specimens, and a TaqMan 
real-time PCR was performed to 
detect  M. pneumoniae as described 
(8). MLVA typing was performed on 
the same DNA extracts, according to 
the method of Dégrange et al. (7). M. 
pneumoniae–speciﬁ   c IgM and IgG 
in serum specimens were assessed 
by ELISA. PCR was used to detect 
Bordetella pertussis, B. parapertussis, 
Chlamydia pneumoniae,  Strepto-
coccus pneumoniae, and viruses 
commonly responsible for respiratory 
tract infections. In France, 10% of M. 
pneumoniae isolates are resistant to 
macrolides (9); thus, we used real-
time PCR and melting curve analysis 
to detect macrolide resistance–
associated mutations in the 23S rRNA 
gene (9).
The 7 children were conﬁ  rmed 
to be positive for M. pneumoniae 
infection by PCR or by the presence 
of  M. pneumoniae–speciﬁ  c  IgM 
(Figure). No other respiratory tract 
pathogens were found. In all cases, 
MLVA determined the strain type to 
be 34572, also called MLVA type J 
(7); this ﬁ  nding suggests clonal spread 
of a speciﬁ  c  M. pneumoniae strain. 
No macrolide resistance–associated 
mutation was found in the 23S rRNA 
gene. All children were treated with 
roxithromycin or clarithromycin 
and rapidly recovered, although 
PCR results remained positive for 
up to 6 weeks in subsequent throat 
samples. This length of persistence is 
in accordance with a previous study 
showing that the median time for 
carriage of M. pneumoniae DNA was 
7 weeks after disease onset and that 
adequate treatment did not shorten this 
period (10). 
M. pneumoniae DNA was also 
found in throat swab specimens of 
3 household contacts (2 adults and 
a 1-year-old child) in 3 separate 
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Figure. Timing and characteristics of patients and contacts in a study using the multilocus 
variable-number tandem repeat (MLVA) typing method to show evidence of clonal spread 
of a unique strain of Mycoplasma pneumoniae among children attending a French primary 
school and their household contacts. Dates correspond to the date of specimen collection 
during December 30, 2010–February 1, 2011. Figure shapes indicate affected children, 
by age in years; white house shapes indicate asymptomatic household contacts; black 
house shapes indicate household contacts with respiratory symptoms. PCR+, throat 
swab specimen positive by M. pneumoniae–speciﬁ  c real-time PCR; PCR−, throat swab 
specimen negative by M. pneumoniae–speciﬁ  c real-time PCR; type J, MLVA type J; type 
ND, MLVA type not determined; *PCR performed after an 8-day macrolide treatment; IgG+, 
IgM+, presence of speciﬁ  c M. pneumoniae IgG and IgM in serum; IgG–, IgM–, absence of 
speciﬁ  c M. pneumoniae IgG or IgM, respectively, in serum.LETTERS
families (Figure). The MLVA type 
was determined in 1 contact; it also 
was MLVA type J, suggesting that 
carriage in this contact was related to 
spread of the same clone. Of interest, 
none of these 3 household members 
had respiratory symptoms. Nilsson et 
al. (10) also reported a high frequency 
of  M. pneumoniae DNA carriage 
in household contacts; however, in 
contrast to contacts in our study, all 
of the household contacts in the study 
by Nilsson et al. had ongoing or recent 
respiratory tract symptoms. 
In summary, we report an 
outbreak of M. pneumoniae infections 
conﬁ  rmed by MLVA, a discriminatory 
typing method. MLVA typing revealed 
the clonal spread of a single M. 
pneumoniae type J strain in children 
attending the same primary school 
and in their household contacts. The 
cases we identiﬁ  ed may represent only 
a small proportion of the actual cases, 
which were likely underestimated due 
to mild symptoms, poor knowledge 
of  M. pneumoniae infections by 
general practitioners, and lack of PCR 
availability. We showed that MLVA 
typing of M. pneumoniae can be used 
to detect clonal spread and outbreaks. 
This approach might also be useful for 
studying the worldwide emergence of 
M. pneumoniae macrolide resistance 
and for ﬁ  nding resistant clones with 
the potential for spreading.
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Risk for Emergence 
of Dengue and 
Chikungunya Virus 
in Israel
To the Editor: In recent years, 
Aedes albopictus, a mosquito vector 
of dengue and chikungunya viruses, 
has rapidly expanded in Europe. Since 
2007, the presence of viremic patients 
with imported cases of dengue and 
chikungunya virus infection has 
resulted in several incidences of 
autochthonous transmission of the 
viruses in Italy, France, and Croatia 
(1–4).
A. albopictus mosquitoes have 
invaded Israel since 2002. A recent 
national survey showed wide 
distribution of the mosquito in Israel 
(5), and dengue and chikungunya 
virus infection are increasingly 
reported in travelers from Israel 
who return home from trips to other 
countries (6,7). We looked for overlap 
between the distribution areas of A. 
albopictus mosquitoes in Israel and 
the living areas of travelers who have 
returned to Israel with acute dengue 
or chikungunya virus infections. 
We discuss the possibility of 
autochthonous transmission of these 
viruses in Israel.
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